INTEGRATED ASSESSMENT OF STATIN-ASSOCIATED MUSCLE DAMAGE PREDICTORS IN PATIENTS WITH ISCHEMIC HEART DISEASE
<p>Aim. To assess the risk factors of statin-associated muscle damage in patient with ischemic heart disease.<br />Material and methods. 258 patients with ischemic heart disease treated with statin were included into the study. Total plasma creatine kinase levels were measured and SLCO1B...
Main Authors: | V. I. Petrov, O. N. Smuseva, Yu. V. Solovkina |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2015-09-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | http://www.rpcardio.ru/jour/article/view/33 |
Similar Items
-
APPLIED ASPECTS OF SLCO1B1 PHARMACOGENETIC TESTING FOR PREDICTING OF STATIN-INDUCED MYOPATHY AND PERSONALIZATION OF STATINS THERAPY
by: D. A. Sychev, et al.
Published: (2015-09-01) -
INTEGRATED ASSESSMENT OF STATIN-ASSOCIATED MUSCLE DAMAGE PREDICTORS IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: V. I. Petrov, et al.
Published: (2015-09-01) -
Damage of the Muscle System in Covid-19
by: I. T. Murkamilov, et al.
Published: (2021-03-01) -
STATINS AND MYOPATHY: MOLECULAR MECHANISMS
by: O. M. Drapkina, et al.
Published: (2015-12-01) -
MYOPATHY AS A SIDE EFFECT OF STATIN THERAPY: MECHANISMS OF DEVELOPMENT AND PROSPECTS FOR TREATMENT
by: O. M. Drapkina, et al.
Published: (2015-09-01)